Research ArticleCancer

Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)

See allHide authors and affiliations

Science Signaling  09 Oct 2018:
Vol. 11, Issue 551, eaat9773
DOI: 10.1126/scisignal.aat9773

Article Information

vol. 11 no. 551

PubMed: 
Published By: 
Print ISSN: 
Online ISSN: 
History: 
  • Received April 24, 2018
  • Accepted September 7, 2018

Author Information

Altmetric

Article usage

Article usage: October 2018 to June 2019

AbstractFullPdf
Oct 201819688661409
Nov 20184279657
Dec 20182284730
Jan 20191406628
Feb 20191233324
Mar 20191434530
Apr 20191384325
May 20191272314
Jun 2019732223